NURCHI, VALERIA MARINA
 Distribuzione geografica
Continente #
EU - Europa 246.798
NA - Nord America 16.127
AS - Asia 6.542
SA - Sud America 1.028
AF - Africa 176
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 270.704
Nazione #
IT - Italia 239.860
US - Stati Uniti d'America 15.864
NL - Olanda 2.973
SG - Singapore 2.475
CN - Cina 2.279
UA - Ucraina 1.148
BR - Brasile 811
SE - Svezia 802
VN - Vietnam 527
DE - Germania 515
FI - Finlandia 444
GB - Regno Unito 364
FR - Francia 323
HK - Hong Kong 194
IN - India 192
KR - Corea 170
CA - Canada 155
BD - Bangladesh 145
IQ - Iraq 73
TR - Turchia 73
RU - Federazione Russa 71
AR - Argentina 63
MX - Messico 62
IR - Iran 54
JP - Giappone 53
ZA - Sudafrica 52
ES - Italia 51
PL - Polonia 48
EC - Ecuador 40
PK - Pakistan 39
ID - Indonesia 35
UZ - Uzbekistan 35
AT - Austria 30
MY - Malesia 29
BE - Belgio 28
CO - Colombia 28
AU - Australia 25
PH - Filippine 23
IE - Irlanda 22
MA - Marocco 22
EG - Egitto 21
VE - Venezuela 21
TN - Tunisia 20
CH - Svizzera 19
CL - Cile 18
TH - Thailandia 18
UY - Uruguay 18
JM - Giamaica 17
SA - Arabia Saudita 17
IL - Israele 14
KE - Kenya 14
PE - Perù 13
DZ - Algeria 11
LY - Libia 11
SY - Repubblica araba siriana 11
CZ - Repubblica Ceca 10
JO - Giordania 10
RO - Romania 9
AL - Albania 8
AZ - Azerbaigian 8
BG - Bulgaria 8
CR - Costa Rica 8
GR - Grecia 8
PY - Paraguay 8
RS - Serbia 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DK - Danimarca 7
LB - Libano 7
KZ - Kazakistan 6
LT - Lituania 6
NP - Nepal 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
BY - Bielorussia 5
ET - Etiopia 5
HU - Ungheria 5
MD - Moldavia 5
NG - Nigeria 5
PS - Palestinian Territory 5
AM - Armenia 4
CI - Costa d'Avorio 4
EU - Europa 4
GT - Guatemala 4
LK - Sri Lanka 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BH - Bahrain 3
KG - Kirghizistan 3
MN - Mongolia 3
PA - Panama 3
BS - Bahamas 2
BW - Botswana 2
EE - Estonia 2
GD - Grenada 2
GE - Georgia 2
KH - Cambogia 2
KW - Kuwait 2
Totale 270.678
Città #
Cagliari 235.097
Uta 3.910
Amsterdam 2.942
Fairfield 1.696
Ashburn 1.315
Woodbridge 1.283
Singapore 1.119
San Jose 922
Houston 883
Chandler 832
Dallas 732
Wilmington 696
Ann Arbor 688
Boardman 684
Seattle 637
Jacksonville 620
Cambridge 588
Nyköping 573
Beijing 408
Dearborn 338
Helsinki 260
Los Angeles 250
Nanjing 195
Boston 191
Lauterbourg 190
The Dalles 190
Santa Clara 189
Hong Kong 166
Ho Chi Minh City 163
Hefei 161
Seoul 153
Council Bluffs 143
New York 143
Hanoi 126
Buffalo 121
Shanghai 121
San Diego 95
Escalaplano 79
Guangzhou 73
Nanchang 72
São Paulo 71
Redwood City 70
Shenyang 61
Dong Ket 60
Milan 59
Hebei 57
Orem 52
London 51
Mountain View 51
Tianjin 51
Toronto 50
Changsha 49
Redondo Beach 46
Atlanta 44
Chicago 43
Chennai 41
Jiaxing 39
Verona 39
Baghdad 35
Frankfurt am Main 34
Norwalk 33
Ottawa 33
Tokyo 33
Sassari 32
Tashkent 32
Zhengzhou 32
Rome 31
Brooklyn 30
Rio de Janeiro 30
Columbus 27
Da Nang 27
Jinan 26
Orange 26
Brussels 25
Warsaw 25
Nuremberg 24
Phoenix 24
Dhaka 23
Washington 23
Hangzhou 22
Pune 21
Auburn Hills 18
Haiphong 18
Las Vegas 18
Ningbo 18
Dublin 17
Johannesburg 17
Paris 17
Wuhan 17
Brasília 16
Istanbul 16
Manchester 16
Montreal 16
Pars 16
Charlotte 15
Falls Church 15
San Francisco 15
Belo Horizonte 14
Curitiba 13
Guayaquil 13
Totale 260.931
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.751
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.854
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.632
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.552
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.539
Multiple Sclerosis and environmental factors. 3.299
Gold - Old drug with new potentials 3.227
Simple solid-phase spectrophotometric method for free iron(III) determination 3.080
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.940
Sampling variability in hepatic iron concentration in beta-thalassemia 2.873
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.801
Salicylamide derivatives for iron and aluminium sequestration. From synthesis to complexation studies 2.751
The essential metals for humans: a brief overview 2.708
Assessment, validation and application to real samples of an RP-HPLC method for the determination of Guayulins A, B, C and D in Guayule Shrub 2.658
Looking at new ligands for chelation therapy 2.562
Sorption of ofloxacin and chrysodine by grape stalk. A representative case of biomass removal of emerging pollutants from wastewater 2.545
Depleted uranium and human health 2.470
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.444
Copper-Induced Epigenetic Changes Shape the Clinical Phenotype in Wilson's Disease 2.437
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.413
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.303
Gold nanoparticles: A new golden Era in oncology? 2.279
Metal self-assembly mimosine peptides with enhanced antimicrobial activity: towards a new generation of multitasking chelating agentsts 2.251
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.231
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.229
Chelating principles in Menkes and Wilson diseases: Choosing the right compounds in the right combinations at the right time 2.228
Do anti-diabetic drugs act as copper ligands? 2.213
New insights into the protogenic and spectroscopic properties of commercial tannic acid: the role of gallic acid impurities 2.204
Free fluoride determination in honey by ion-specific electrode potentiometry: method assessment, validation and application to real unifloral samples 2.200
Toxicity of nanoparticles: etiology and mechanisms 2.156
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.117
Arsenic toxicity: Molecular targets and therapeutic agents 2.081
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.075
Tungsten or wolfram: Friend or foe? 2.055
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.042
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 2.030
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.976
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.968
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.959
The meaning of aluminium exposure on human health and aluminium-related diseases 1.928
Kill or cure: Misuse of chelation therapy for human diseases 1.927
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.900
A portable, disposable, and low-cost optode for sulphide and thiol detection 1.899
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.895
Silver coordination compounds: A new horizon in medicine 1.876
Alarming use of chelation therapy 1.851
Inexpensive Alizarin Red S-based optical device for the simultaneous detection of Fe(III) and Al(III) 1.850
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.838
Oxovanadium(IV) coordination compounds with kojic acid derivatives in aqueous solution 1.831
Chemical features of in use and in progress chelators for iron overload 1.829
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.824
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.805
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.799
State of art in chelating agents for the clinical treatment of metal poisoning 1.795
Noble metals in medicine: Latest advances 1.786
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.783
Biomonitoring of toxic element exposure by ICP-AES and ICP-MS analysis 1.777
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.767
5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one molecule as an intriguing tool in coordination and enzymatic studies 1.764
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.739
Unusual PLS application for Pd(ii) sensing in extremely acidic solutions 1.734
Medical uses of silver: history, myths and scientific evidence 1.726
Chelating agents as therapeutic compounds - Basic principles 1.712
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.711
null 1.693
Sorption of chrysoidine by row cork and cork entrapped in calcium alginate beads 1.688
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.681
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.657
Losartan: a low water soluble oral drug with Cu(II) and Zn(II) coordination properties 1.627
Uneven hepatic copper distribution in Wilson's disease 1.620
Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents 1.615
Trace elements and the carotid plaque: the GOOD (Mg, Zn, Se), the UGLY (Fe, Cu), and the BAD (P, Ca)? 1.597
Synthesis and Mass Spectrometry Analysis of Mimosine-Containing Peptides 1.588
Chelating agents for human diseases related to aluminium overload 1.561
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification 1.524
Uneven cardiac iron distribution in beta-thalassemia 1.514
Biomass against emerging pollution in wastewatee 1.490
Medicinal bio-inorganic chemistry: papers from the Third International Summer School of Bioinorganic Medicinal Chemistry, Cagliari, Italy 1.433
Optimization of a newly established gas-chromatographic method for determining lactose and galactose traces: Application to Pecorino Romano cheese 1.391
Toxicity of nanoparticles 1.386
Development of a sensor for trivalent iron: AHP fixed on mesoporous silica 1.320
Copper(II) and Nickel(II) uptake from aqueous solutions by cork wastes: a NMR and potentiometric study 1.311
Biomass against emerging pollution in wastewater: Ability of cork for the removal of ofloxacin from aqueous solutions at different pH 1.308
Chelating agents for metal intoxication 1.307
The Potential Clinical Properties of Magnesium 1.304
Deferoxamine-paper for iron(III) and vanadium(V) sensing 1.250
Iron chelating agents for iron overload diseases 1.241
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.239
Metal ion toxicity 1.239
Molecular recognition between adenine or 2,6-diaminopurine and copper(II) chelates with N,O2,S-tripodal tetradentate chelators having thioether or disulfide donor groups. 1.237
Warns against unapproved ‘chelation therapy’ 1.206
null 1.188
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.167
Medical therapy of patients contaminated with radioactive cesium or iodine 1.164
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.163
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.157
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.118
null 1.075
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.072
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.060
Totale 196.670
Categoria #
all - tutte 360.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 360.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.188 0 0 0 0 0 0 0 0 0 0 0 2.188
2021/202212.527 1.465 1.310 696 960 1.077 949 652 479 891 1.213 1.478 1.357
2022/202317.894 1.410 1.911 2.066 1.412 1.487 2.109 997 2.372 1.204 920 1.158 848
2023/202419.038 1.041 839 846 1.302 2.034 3.370 2.863 1.276 726 1.437 1.687 1.617
2024/202541.563 10.259 11.022 4.737 3.838 2.235 2.611 3.586 261 510 1.530 404 570
2025/202614.049 754 497 1.452 896 657 949 2.547 1.029 3.135 1.158 703 272
Totale 271.276